Ancer Kidney News Today

After years of working with the National Cancer Institute, W. Kimryn Rathmell, MD, PhD, gets the call to run the institute.

In this cohort study, researchers identified 6146 patients from 17 registries of the SEER Program who had been diagnosed with a first primary cutaneous Merkel cell carcinoma between 2000 and 2018.

A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types.

However, a post-hoc analysis adds to evidence suggesting that irradiating all metastatic lesions may improve survival in patients receiving immune checkpoint inhibitor monotherapy.

First study to show obesity-related cancer risk is 1.5-fold higher in people with metabolic aberrations as well as obesity, compared with metabolically healthy and normal weight individuals.

Its not a magic bullet, but the stories of transformation are profound, the lead investigator said.

Combining Modernas patient-specific mRNA-based cancer vaccine with pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma vs pembrolizumab alone, new data show.

After finding that immune checkpoint inhibitors (ICIs) do not work as well for patients who had taken antibiotics, the investigators suggest restoring the gut microbiome before starting therapy.

Twelve genetic mutations in clear-cell renal cell carcinoma may predict which patients will experience recurrence; they could also help personalize adjuvant treatment, researchers say.

A unique study in patients with renal cell carcinoma on tyrosine kinase inhibitors (TKIs) shows that taking a break from the drugs is feasible and cost-effective.